Who is sponsoring NCT02478515?

NCT02478515 is sponsored by Nagoya City University.

What condition does NCT02478515 study?

NCT02478515 studies Branch Retinal Vein Occlusion.

What is the status of NCT02478515?

NCT02478515 is currently COMPLETED.

Last reviewed 2019-08-17 · How we verify

Evaluation of Visual Acuity Improvement of a PRN Regimen Using Ranibizumab for Macular Edema Due to Ischemic and Non- Ischemic Branch Retinal Vein Occlusion.

NCT02478515 Phase 4 COMPLETED

Monthly intravitreal ranibizumab (IVR) during the first 6 month had great effect for macular edema with branch retinal vein occlusion (BVO) both in visual and anatomical outcome. It is expected that similar results could be obtained by less frequent IVR. The purpose of this study is to investigate if IVR by PRN is as effective as by monthly. In addition, the investigators are going to study the relationship between macular edema and the size and location of retinal non-perfusion area.

Details

Lead sponsor	Nagoya City University
Phase	Phase 4
Status	COMPLETED
Enrolment	27
Start date	2014-01
Completion	2019-03

Conditions

Branch Retinal Vein Occlusion

Interventions

Ranibizumab

Primary outcomes

Visual acuity — One years

Countries

Japan